Bacterial contamination of blood products: factors, options, and insights

scientific article

Bacterial contamination of blood products: factors, options, and insights is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1002/JCA.10004
P698PubMed publication ID11835416

P2093author name stringBrecher ME
Hay SN
Depcik-Smith ND
P2860cites workTransfusion medicine. First of two parts--blood transfusionQ28296931
Septic reactions to platelet transfusions. A persistent problemQ33390611
Approaches to the detection of bacterial contamination in cellular blood productsQ33602575
Leukocyte reduction of blood components: public policy and new technologyQ33835138
Visual identification of bacterially contaminated red cellsQ35971406
Improving blood transfusion practice: role of a computerized hospital information systemQ35971415
Near-IR dyes in three-color volumetric capillary cytometry: cell analysis with 633- and 785-nm laser excitationQ36793362
A prospective study of symptomatic bacteremia following platelet transfusion and of its managementQ40694155
Strategies for the avoidance of bacterial contamination of blood componentsQ40720704
The role of white cells in the transmission of Yersinia enterocolitica in blood componentsQ41110503
Pseudomonas Species Bacteremia Caused by Contaminated Normal Human Serum AlbuminQ41251149
Transfusion transmitted Yersinia enterocolitica infection in New ZealandQ41393958
Inhibitory effect of 0 degree C storage on the proliferation of Yersinia enterocolitica in donated bloodQ41488088
Yersinia enterocolitica septicemia in autologous blood transfusionQ41498138
Modeling the growth of Yersinia enterocolitica in donated bloodQ41499620
The use of a chemiluminescence‐linked universal bacterial ribosomal RNA gene probe and blood gas analysis for the rapid detection of bacterial contamination in white cell‐reduced and nonreduced plateletsQ41503213
Direct identification of Yersinia enterocolitica in blood by polymerase chain reaction amplificationQ41504924
Prevention of Yersinia enterocolitica growth in red-blood-cell concentratesQ41505265
Growth of Yersinia species in artificially contaminated blood bagsQ41505289
Removal of Yersinia enterocolitica from AS-1 red cellsQ41505297
Prevention of growth of Yersinia enterocolitica in blood by polyester fiber filtrationQ41505304
Prestorage removal of Yersinia enterocolitica from red cells with white cell-reduction filtersQ41505447
Screening blood donors for gastrointestinal illness: a strategy to eliminate carriers of Yersinia enterocoliticaQ41508588
Sepsis associated with transfusion of red cells contaminated with Yersinia enterocoliticaQ41511999
Limits to progressive reduction of resident skin bacteria by disinfectionQ41631057
Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet lightQ42982277
Allogeneic blood transfusions, immunomodulation, and postoperative bacterial infection: do we have the answers yet?Q43564908
Evaluation of an automated culture system for detecting bacterial contamination of platelets: an analysis with 15 contaminating organismsQ43584972
Photochemical inactivation of bacteria and HIV in buffy-coat-derived platelet concentrates under conditions that preserve in vitro platelet functionQ43655377
A prospective microbiologic surveillance program to detect and prevent the transfusion of bacterially contaminated plateletsQ44579149
Evaluation of swirling, pH, and glucose tests for the detection of bacterial contamination in platelet concentratesQ44887859
Automatic volumetric capillary cytometry for counting white cells in white cell-reduced plateletpheresis componentsQ46158593
Safety of human albumin as a constituent of biologic therapeutic productsQ47771041
Single-donor platelets reduce the risk of septic platelet transfusion reactionsQ49166133
Effect of prestorage white cell reduction on bacterial growth in platelet concentratesQ50161992
Salmonella septicemia from platelet transfusions. Study of an outbreak traced to a hematogenous carrier of Salmonella cholerae-suisQ50235023
A multicenter evaluation of reproducibility of swirling in platelet concentrates. Biomedical Excellence for Safer Transfusion (BEST) Working Party of the International Society of Blood Transfusion.Q53381510
Enterobacter cloacae bloodstream infections traced to contaminated human albuminQ64131063
White cell reduction and bacterial proliferationQ70774937
Platelet bacterial contamination and the use of a chemiluminescence‐ linked universal bacterial ribosomal RNA gene probeQ71647521
Transfusion-transmitted Serratia liquifaciens from an autologous blood unitQ72157215
Operating theatre water-baths as a cause of pseudomonas septicaemiaQ72659789
Septic shock due to Yersinia enterocolitica after autologous transfusionQ72720538
A novel screening method for the detection of microbial contamination of platelet concentrates. An experimental pilot studyQ72779191
Current status of microbial contamination of blood components: summary of a conferenceQ73048315
Growth of bacteria in inoculated platelets: implications for bacteria detection and the extension of platelet storageQ73251514
Rapid identification of bacterially contaminated platelets using reagent strips: glucose and pH analysis as markers of bacterial metabolismQ73277637
A general method for concentrating blood samples in preparation for counting very low numbers of white cellsQ73277654
Evaluation of donor skin disinfection methodsQ73277667
Coagulase-negative staphylococcal contamination of whole blood and its components: the effects of WBC reductionQ73337470
Efficacy of a new collection procedure for preventing bacterial contamination of whole-blood donationsQ73402681
Antibiotic-labeled probes and microvolume fluorimetry for the rapid detection of bacterial contamination in platelet components: a preliminary reportQ73693310
Blood usage in lung transplantationQ74242634
Collection and transfusion of blood and blood components in the United States, 1994Q74820036
Skin fragments removed by injection needlesQ78430832
P433issue4
P304page(s)192-201
P577publication date2001-01-01
P1433published inJournal of Clinical ApheresisQ15765490
P1476titleBacterial contamination of blood products: factors, options, and insights
P478volume16

Reverse relations

cites work (P2860)
Q34130302Bacterial contamination of pediatric whole blood transfusions in a Kenyan hospital
Q34544130Direct detection of the bacterial stress response in intact samples of platelets by differential impedance.
Q51444129Enhancement of a culture-based bacterial detection system (eBDS) for platelet products based on measurement of oxygen consumption.
Q45186203In vitro evaluation of COM.TEC apheresis platelet concentrates using a preparation set and pathogen inactivation over a storage period of five days
Q44331869Inactivation of pathogens in platelet concentrates by using a two-step procedure
Q61814294Multi-Method Characterization of the Human Circulating Microbiome
Q33361167Optimizing platelet transfusion therapy
Q44166128Postoperative red blood cell transfusion and morbid outcome in uncomplicated cardiac surgery patients
Q36106339Protecting the blood supply from emerging pathogens: the role of pathogen inactivation
Q37208865Rapid screening by real-time 16S rDNA PCR for bacterial contamination of blood products
Q50740074Sterility testing of platelet concentrates prepared from deliberately infected blood donations.
Q35675880The mantra of blood safety: time for a new tune?
Q43046980The microbiologic safety of umbilical cord blood transfusion for children with severe anemia in Mombasa, Kenya
Q37575280Two novel real-time reverse transcriptase PCR assays for rapid detection of bacterial contamination in platelet concentrates
Q46079804Two-year experience with aerobic culturing of apheresis and whole blood-derived platelets
Q79789964[New container of sample: role in the reduction of bacterial contamination of standard platelet units]

Search more.